REQUEST A DEMO
Total
USD $0.00
Search more companies

Logifarma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Logifarma S.A.S. Profile Updated: December 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Logifarma S.A.S. is a company in Colombia, with a head office in Barranquilla. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on February 21, 2006. The total number of employees is currently 1 (2023). From the latest financial highlights, Logifarma S.A.S. reported a net sales revenue increase of 20.5% in 2023. There was a total growth of 56.88% in Logifarma S.A.S.’s total assets over the same period. In, 2023, the company’s net profit margin increased by 4.1%.

Headquarters
Cl 77 B No 57 - 103 Torre 1 - 902 Edificio Green Towers
Barranquilla; Atlantico;

Contact Details: Purchase the Logifarma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Logifarma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Logifarma S.A.S. report to view the information.
Incorporation Date:
February 21, 2006
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Company Performance
Financial values in the chart are available after Logifarma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
20.5%
Total operating revenue
20.51%
Operating profit (EBIT)
90.46%
EBITDA
81.55%
Net Profit (Loss) for the Period
275.62%
Total assets
56.88%
Total equity
75.58%
Operating Profit Margin (ROS)
3.1%
Net Profit Margin
4.1%
Return on Equity (ROE)
22.92%
Debt to Equity Ratio
2.33%
Quick Ratio
0.17%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?